Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone versus hypertonic dextrose injection for knee osteoarthritis
IRCT20191002044951N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in knee osteoarthritis (OA) comparing Triamcinolone injection with Hypertonic dextrose injection (2 arms). Primary endpoints: Pain severity at 3 months, WOMAC score at 3 months and 1 more. Started Nov 2019; status: completed.
02
Drugs
triamcinolonedextrose
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20191002044951N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191002044951N1.